Nicotinic Acid for the Treatment of Alzheimer's Disease

NCT06582706 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Placebo Comparator
DRUG: Extended Release Niacin

Sponsor

Indiana University

Collaborators

[object Object]